We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXTA icon
926
Axalta
AXTA
$7.93B
– –
-342
Closed -$9K
BABA icon
927
Alibaba
BABA
$295B
– –
-7,950
Closed -$1.29M
BABA icon
928
PUT
Alibaba
BABA
$295B
– –
-100
Closed -$17K
BANC icon
929
Banc of California
BANC
$3.14B
$0 ﹤0.01%
50
– –
BBAI icon
930
BigBear.ai
BBAI
$1.57B
– –
-14
Closed –
BCE icon
931
CALL
BCE
BCE
$21.6B
– –
-508
Closed -$11K
BCTX
932
Briacell Therapeutics
BCTX
$29.8M
$0 ﹤0.01%
10
– –
BE icon
933
PUT
Bloom Energy
BE
$72.8B
– –
-12
Closed -$1K
BETR icon
934
Better Home & Finance Holding
BETR
$21.9M
– –
-525
Closed -$29K
BFK
935
DELISTED
BlackRock Municipal Income Trust
BFK
– –
-800
Closed -$8K
BFZ
936
DELISTED
BlackRock CA Municipal Income Trust
BFZ
– –
-200
Closed -$2K
BGH
937
Barings Global Short Duration High Yield Fund
BGH
$286M
– –
-800
Closed -$12K
BHC icon
938
Bausch Health
BHC
$2.36B
$0 ﹤0.01%
+30
New +$197
BHF icon
939
Brighthouse Financial
BHF
$3.44B
– –
-6,788
Closed -$399K
BIBL icon
940
Inspire 100 ETF
BIBL
$506M
– –
-50
Closed -$2K
CMRC
941
Commerce.com Inc Series 1
CMRC
$182M
– –
-2,000
Closed -$9K
BIIB icon
942
Biogen
BIIB
$30.9B
– –
-13
Closed -$1K
BILI icon
943
Bilibili
BILI
$7.14B
– –
-52,000
Closed -$1.46M
BKNG icon
944
PUT
Booking.com
BKNG
$160B
– –
-25
Closed -$5K
BKN
945
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
– –
-300
Closed -$3K
BKR icon
946
CALL
Baker Hughes
BKR
$62.9B
– –
-54
Closed -$2K
BKR icon
947
Baker Hughes
BKR
$62.9B
– –
-2,805
Closed -$136K
BKSY icon
948
BlackSky Technology
BKSY
$1.28B
– –
-2,947
Closed -$59K
SRTA
949
Strata Critical Medical Inc
SRTA
$533M
– –
-2,730
Closed -$13K
BLDR icon
950
CALL
Builders FirstSource
BLDR
$7.99B
– –
-45
Closed -$5K
36 37
38
39 40

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.